Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination - Ivanko, I.; Ćelap, I.; Margetić, S.; Marijančević, D.; Josipović, J.; Gaćina, P. (Thrombosis research, 2023)
Keywords: Ad26COVS1; Blood Coagulation; BNT162 Vaccine; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines - adverse effects; Full Length; Haemostasis; Hematology, Oncology, and Palliative Medicine; Humans; Inflammation; RNA, Messenger; SARS-CoV-2; Vaccination - adverse effects; Vaccine; COVID-19; Vaccine; Inflammation; Haemostasis